نتایج جستجو برای: organ at risk

تعداد نتایج: 4378334  

2003
Jianqing Fan Juan Gu

Value at Risk measures the worst loss to be expected of a portfolio over a given time horizon at a given confidence level. Calculation of VaR frequently involves estimating the volatility of return processes and quantiles of standardized returns. In this paper, several semiparametric techniques are introduced to estimate the volatilities . In addition, both parametric and nonparametric techniqu...

2002
Jeroen Kerkhof Bertrand Melenberg

In this paper we present a framework for backtesting all currently popular risk measurement methods (including value-at-risk and expected shortfall) using the functional delta method. Estimation risk can be taken explicitly into account. Based on a simulation study we provide evidence that tests for expected shortfall with acceptable low levels have a better performance than tests for value-at-...

Journal: :Annals OR 2010
Frank J. Fabozzi Dashan Huang Guofu Zhou

In this paper we provide a survey of recent contributions to robust portfolio strategies from operations research and finance to the theory of portfolio selection. Our survey covers results derived not only in terms of the standard mean-variance objective, but also in terms of two of the most popular risk measures, mean-VaR and mean-CVaR developed recently. In addition, we review optimal estima...

Journal: :Reports of Practical Oncology & Radiotherapy 2017

K Srivastava M L B Bhatt, N K Painuly N Singh, S P Mishra S Singh, Sh Srivastava,

Background: Brachytherapy treatment planning in cervix carcinoma patients using two dimensional (2D) orthogonal images provides only point dose estimates while CT-based planning provides volumetric dose assessment helping in understanding the correlation between morbidity and the dose to organs at risk (OARs) and treatment volume. Objective: Aim of present study is to compare Internationa...

2009
Renato Pelessoni Paolo Vicig Marco Zaffalon

We explore generalizations of the pari-mutuel model (PMM), a formalization of an intuitive way of assessing an upper probability from a precise one. We discuss a naive extension of the PMM considered in insurance and generalize the natural extension of the PMM introduced by P. Walley and other related formulae. The results are subsequently given a risk measurement interpretation: in particular ...

2017
Amir Ahmadi-Javid Alois Pichler

This paper addresses the Entropic Value-at-Risk (EV@R), a recently introduced coherent risk measure. It is demonstrated that the norms induced by EV@R induce the same Banach spaces, irrespective of the confidence level. Three spaces, called the primal, dual, and bidual entropic spaces, corresponding with EV@R are fully studied. It is shown that these spaces equipped with the norms induced by EV...

1996
ALEXEI CHEKHLOV

A new one-parameter family of risk measures called Conditional Drawdown (CDD) has been proposed. These measures of risk are functionals of the portfolio drawdown (underwater) curve considered in active portfolio management. For some value of the tolerance parameter α, in the case of a single sample path, drawdown functional is defined as the mean of the worst (1 − α) ∗ 100% drawdowns. The CDD m...

2013
Ramon Alemany Catalina Bolancé

In this paper we analyse nonparametric methods to estimate risk measures in loss distributions. We study kernel estimation for Value-at-Risk and Tail Value-at-Risk based on transformation of the original data. The proposed method consists of a double transformation kernel estimation. We show that a suitable bandwidth selection criterion has a direct expression for the optimal smoothing paramete...

2018
Daniëlle B.P. Eekers Lieke in 't Ven Sabine Deprez Linda Jacobi Erik Roelofs Ann Hoeben Philippe Lambin Dirk de Ruysscher Esther G.C. Troost

Eekers et al. have recently proposed a neuro-oncology atlas, which was co-authored by most centers associated in the European Proton Therapy Network (EPTN; Figure 1). With the introduction of new treatment techniques, such as integrated magnetic resonance imaging and linear accelerators (MR-linac) or particle therapy, the prediction of clinical efficacy of these more costly treatment modalities...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید